Navigation Links
Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting
Date:6/1/2009

Carfilzomib Achieves 26 Percent Clinical Benefit Response Rate in Phase 2 Trial of Relapsed and Refractory Multiple Myeloma Patients - Proteolix Expands Trial

ORLANDO, Fla. and SOUTH SAN FRANCISCO, Calif., June 1 /PRNewswire/ -- Proteolix, Inc. today presented results from the company's most advanced clinical trial of single-agent carfilzomib demonstrating anti-cancer activity and progression-free survival in patients with relapsed and refractory multiple myeloma. Carfilzomib is the first in a new class of selective, irreversible proteasome inhibitors being developed by Proteolix for the treatment of hematologic malignancies and solid tumors.

Data from the Phase 2 clinical trial of relapsed and refractory multiple myeloma patients were presented today in an oral session by Sundar Jagannath, M.D., Chief of the Multiple Myeloma Program, Bone Marrow and Blood Stem Cell Transplantation at St. Vincent's Comprehensive Cancer Center in New York, at the 2009 Annual Meeting of the American Society of Clinical Oncology (ASCO). In addition, Proteolix presented positive data today from an ongoing Phase 2 clinical trial of single-agent carfilzomib in relapsed multiple myeloma patients and from a Phase 1b clinical trial of carfilzomib in combination with lenalidomide and dexamethasone during the "Lymphoma and Plasma Cell Disorders" poster session.

"In spite of advances in the treatment of multiple myeloma, new selective agents are needed for patients who have failed other available therapies," said Dr. Jagannath. "Carfilzomib is well tolerated and demonstrates clear single-agent activity in a heavily pre-treated multiple myeloma patient population. Patients enrolled in this Phase 2 trial lack treatment alternatives, having failed prior treatment with all approved agents and stem cell transplant."

Sustained Clinical Benefit in Relapsed and Refractory Patients

The Phase 2 clinical trial
'/>"/>

SOURCE Proteolix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Proteolix Presents Phase 1b/2 Clinical Data for Carfilzomib in Advanced Solid Tumor Patients at the 2009 ASCO Annual Meeting
2. Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology
3. Proteolix Initiates Phase 1b Clinical Trial of Carfilzomib in a Combination Regimen for Patients With Relapsed Multiple Myeloma
4. Proteolix Initiates Phase 2 Clinical Trial of Carfilzomib in Patients With Relapsed Solid Tumors
5. Proteolix Initiates Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients
8. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
9. TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
10. Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting
11. MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... , June 29, 2015  PDL BioPharma, Inc. ... entered into a credit agreement with CareView Communications, Inc. ... to $40 million of secured debt financing. CareView is ... on patient care monitoring. Under the credit ... million of debt financing in two tranches of $20 ...
(Date:6/29/2015)... Minn. , June 29, 2015 EnteroMedics ... of devices that use neuroblocking technology to treat obesity, ... it has commenced an underwritten public offering of units. ... stock, Series A warrants to purchase common stock and ... purchase of units in the offering would result in ...
(Date:6/29/2015)... , June 29, 2015  Allergan plc ... intends to release second quarter 2015 financial results ... open of the U.S. financial markets. The Company will ... a.m. Eastern Daylight Time on Thursday, August 6, ... to access the call is U.S./ Canada ...
Breaking Medicine Technology:PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 2PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 4EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 2Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 3
... Radiologic (vRad), a technology-enabled national radiology practice, has again ... market segment by independent research and consulting firm KLAS. ... interviews conducted by KLAS and is published in the ... Software & Professional Services report. In ...
... Reportlinker.com announces that a new market research report ... Novo Nordisk A/S: PharmaVitae Profile ... This analysis examines the historical ... prescription pharmaceutical sector. The profile encompasses global company ...
Cached Medicine Technology:Virtual Radiologic Ranked #1 for Teleradiology Services for Third Consecutive Year 2Reportlinker Adds Novo Nordisk A/S: PharmaVitae Profile 2
(Date:6/30/2015)... Falls Church, VA (PRWEB) , ... June 30, ... ... (APNA) 29th Annual Conference will be held October 28-31, 2015 at Disney’s Coronado ... days of continuing nursing education and networking. Each year, this premiere event for ...
(Date:6/30/2015)... ... 30, 2015 , ... This Fourth of July, Peacock Alley celebrates ... hard work, tenacity, perseverance, commitment to quality, honesty and love of friends and family. ... Ella Gabler's simple love of quilts, Peacock Alley was fully realized and grown while ...
(Date:6/29/2015)... ... June 30, 2015 , ... Sublime Beauty NATURALS® introduces its new USDA ... oil, ideal for natural skincare and even culinary uses, was especially designed for Oil ... people desire, and Oil Pulling can accomplish this. Oil Pulling is an Ayurvedic practice ...
(Date:6/29/2015)... ... 30, 2015 , ... With thousands of children in Utah Valley diagnosed on ... support center, planned at Utah Valley University, in Orem, Utah. The University has ... the building in which it will be housed. , Utah Valley has the highest ...
(Date:6/29/2015)... ... June 29, 2015 , ... Healthpointe, one of ... John A. Mitamura, MD., PhD into their world-class multidisciplinary team of physicians and ... Long Beach , Irwindale and La Tijera-Los Angeles. , Orthopedic surgeons of ...
Breaking Medicine News(10 mins):Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 2Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 3Health News:Luxury Linen Purveyor Peacock Alley Celebrates the Fourth of July 2Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2Health News:doTERRA Partners With Utah Valley University on Autism Support Center 2Health News:doTERRA Partners With Utah Valley University on Autism Support Center 3Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 2Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 3
... alleviate the suffering of shingles could move a step closer ... the go-ahead. A new shingles drug (FV-100), discovered ... of Pharmacy together with a virology group at the Rega ... due to complete Phase II of its clinical trials. ...
... ... 23, 2010 – Phybridge Inc. announced that it has joined the Cisco Developer Network ... has successfully completed interoperability testing with Cisco Unified Communications Manager, 7.1. , ... (PRWEB) March 23, 2010 -- ...
... ... survivors of the earthquake in Haiti. The Grand Canyon University community has donated more than ... on January 12, 2010. , ... Phoenix, AZ (PRWEB) March 23, 2010 -- Grand Canyon University,s Compassion and Generosity ...
... , COLLEYVILLE, Texas , March 23 E ... of the SS Choice No.7 STEALTH, which they originally designed for ... soldiers last summer and has been battle tested in Iraq ... comes in a matte black finish that is difficult to see ...
... , March 23 PSI Ambassador, actress and singer/songwriter ... and dozens of others who met with Members of Congress today ... which included a briefing to Congress, an attempt to form the ... Kerry , Congressman Jim McGovern and students from Oyster-Adams ...
... Yogi Bear’s ... pricing for the 2010 season! Plan an affordable and fun family vacation in North ... resort fees - just memories in the making at this family campground. , ... (PRWEB) March 23, 2010 -- Yogi ...
Cached Medicine News:Health News:Welsh shingles drug set for final hurdle 2Health News:Phybridge Inc. Joins the Cisco Developer Network and Completes Cisco Interoperability Verification Testing 2Health News:Grand Canyon University (GCU) Creates Special Relief Fund and Raises Money for Haiti Earthquake Survivors 2Health News:Combat E-Cigarette in Demand by Civilians 2Health News:Combat E-Cigarette in Demand by Civilians 3Health News:PSI Ambassador Mandy Moore Calls on Congress for Clean Water 2Health News:PSI Ambassador Mandy Moore Calls on Congress for Clean Water 3Health News:PSI Ambassador Mandy Moore Calls on Congress for Clean Water 4Health News:Announcing 2010 Stimulus Pricing on Adirondack Family Vacations 2Health News:Announcing 2010 Stimulus Pricing on Adirondack Family Vacations 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: